Average Ratings 0 Ratings
Average Ratings 0 Ratings
Description
Enhance patient care by using the only objective, quantitative arterial analysis software validated through histology and based on CTA technology. This innovative tool employs ground-truth histological data to reveal the origins of myocardial ischemia, helping to assess risks for heart attacks and strokes. These critical events are often driven by unstable, non-obstructive plaques within the arteries that remain undetected and unaddressed. Traditional non-invasive diagnostic methods fall short, as they cannot penetrate deep into the arterial walls where heart disease begins to manifest. Elucid is leveraging advanced scientific imaging alongside artificial intelligence to facilitate rapid, reliable, and non-invasive diagnoses, ultimately leading to tailored treatment strategies for cardiovascular conditions and improved patient outcomes. With this histology-validated software, you can evaluate plaque composition and determine the risks of heart attacks and strokes with unmatched precision. This comprehensive, objective visualization of arterial health empowers healthcare providers to devise customized treatment approaches well before a patient arrives for hospital care, significantly enhancing the quality of healthcare delivery.
Description
Developed by healthcare professionals for their peers, this technology aims to significantly enhance the quality of life for patients. Our AI-driven platform emphasizes speed, scalability, and security while offering the flexibility and customization that each hospital requires. It serves as a dependable long-term resolution. With RapidAI's stroke portfolio, you can expedite triage and transfer decisions with greater precision. Additionally, it facilitates the swift identification, monitoring, and proactive management of aneurysms. RapidAI's comprehensive suite of products for pulmonary embolism care enables quick detection of suspected PE cases. The AI-enhanced clinical decision support (CDS) software accelerates the decision-making process for physicians; however, it is crucial to recognize that not all AI solutions are equal. Only those CDS tools that possess clinical expertise can accurately identify, locate, characterize, and quantify suspected conditions. This advanced level of precision in AI-powered CDS modules contributes to improved triage and transfer decisions, ultimately leading to enhanced diagnostic accuracy and more efficient vascular care. By integrating these cutting-edge tools, healthcare providers can significantly elevate patient outcomes and operational efficiency.
API Access
Has API
API Access
Has API
Integrations
No details available.
Integrations
No details available.
Pricing Details
No price information available.
Free Trial
Free Version
Pricing Details
Free
Free Trial
Free Version
Deployment
Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook
Deployment
Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook
Customer Support
Business Hours
Live Rep (24/7)
Online Support
Customer Support
Business Hours
Live Rep (24/7)
Online Support
Types of Training
Training Docs
Webinars
Live Training (Online)
In Person
Types of Training
Training Docs
Webinars
Live Training (Online)
In Person
Vendor Details
Company Name
Elucid
Country
United States
Website
elucid.com
Vendor Details
Company Name
RapidAI
Country
United States
Website
www.rapidai.com